BriaCell Therapeutics (TSE:BCT) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
BriaCell Therapeutics announced a share consolidation plan, converting every fifteen pre-consolidation shares into one post-consolidation share to meet Nasdaq listing requirements. The consolidation, effective January 24, 2025, will see the new shares trading from January 29, 2025, ensuring continued compliance and adjusted securities pricing.
For further insights into TSE:BCT stock, check out TipRanks’ Stock Analysis page.
